Objective: To find out the clinical characteristic elements as parameters and detect the polymorphism at PvU II endonuclease site and Arg(140) Trp mutation of the CD38 gene of LADA patients in the Chengdu area.
Methods: The clinical parameters, islet cell-specific autoantibodies, C-peptide levels, genetic and mutation frequency of the CD38 gene in 44 patients with LADA and 67 patients with T2DM were investigated and compared with those in 25 normal controls.
Results: The patients of 30-50 years of age had higher prevalence of LADA. A number of LADA patients were obese or over-obese. The positivity of GAD-Ab, ICA and IAA declined with the increase of age. Both LADA and T2DM patients had the polymorphisms of B/B and A/B of the CD38 gene, but the healthy controls did not have such polymorphisms. Arg1140 Trp mutation was not found in both patients and healthy controls.
Conclusion: This research revealed no relationship between the on-set of LADA and the CD38 polymorphism and CD38 Arg(140) Trp mutation.